0
Position
Professor of Translational & Applied Health Resear
Company
University of Leeds
Location
Leeds UNITED KINGDOM
Bio

Professor of Translational and Applied Health Research at University of Leeds. Director of DenTCRU
Sue's research interests are in Applied Health Research designed to improve NHS treatment and care for patients. She has a particular interest around translational 'pull-through' research-where new innovations being developed in the laboratory can be brought through to successful clinical application. In this capacity she forges multi-disciplinary research partnerships between clinicians, academics, industry and patients; developing methodological robust projects with research questions tailored to NHS priorities and with Patient Public Involvement (PPI) to ensure that patient benefit of the research is maximised. She works closely with engineers and scientists to bring applications through to a range of clinical settings, notably surgery, biomarker application, cancer diagnostics, cardiovascular, musculoskeletal and oral health. Sue maintains an interest in clinical trial/clinical study methodology and is particular interested in how patients and the public interface with new technologies. She has been actively engaged in patient public involvement (PPI) for over 30 years and notably how research teams can work in effective partnership with patients and the public throughout the research cycle to ensure that the resultant research informs an evidence-based approach to clinical decision making but also answer the dilemmas that patients face when choosing a new treatment regime. Sue has also specialised in issues around patient recruitment and retention in clinical research and is working collaboratively to apply econometric modelling to this area. More recently developing industrial partnerships for knowledge transfer opportunities between public and private sector, e.g. i) of key performance indicators for patient recruitment and retention in the industrial sector and how these might be effectively applied in the public sector and ii)how industry can embrace PPI to design improved clinical trials/studies.